메뉴 건너뛰기




Volumn 59, Issue 4, 2016, Pages 386-397

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

(23)  You, Fengtao a,b,c   Jiang, Licui b,c   Zhang, Bozhen b,c   Lu, Qiang d   Zhou, Qiao d   Liao, Xiaoyang d   Wu, Hong d   Du, Kaiqi e   Zhu, Youcai e   Meng, Huimin a   Gong, Zhishu f   Zong, Yunhui b,c   Huang, Lei b,c   Lu, Man b,c   Tang, Jirong b,c   Li, Yafen b,c   Zhai, Xiaochen g   Wang, Xiangling g   Ye, Sisi b,c   Chen, Dan b,c   more..


Author keywords

CAR T therapy; MUC1; seminal vesicle cancer; solid tumor

Indexed keywords

HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MUC1 PROTEIN, HUMAN; MUCIN 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

EID: 84960422579     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-016-5024-7     Document Type: Article
Times cited : (126)

References (59)
  • 1
    • 84931068909 scopus 로고    scopus 로고
    • Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors
    • COI: 1:CAS:528:DC%2BC2MXpvV2rurY%3D, PID: 26065478
    • Abken, H. (2015). Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors. Immunotherapy 7, 535–544.
    • (2015) Immunotherapy , vol.7 , pp. 535-544
    • Abken, H.1
  • 3
    • 24744434192 scopus 로고    scopus 로고
    • MUC1 as a target antigen for cancer immunotherapy
    • COI: 1:CAS:528:DC%2BD2MXhtVOltLfE, PID: 16117706
    • Acres, B., and Limacher, J.M. (2005). MUC1 as a target antigen for cancer immunotherapy. Expert Rev Vaccines 4, 493–502.
    • (2005) Expert Rev Vaccines , vol.4 , pp. 493-502
    • Acres, B.1    Limacher, J.M.2
  • 4
    • 0024454148 scopus 로고
    • Specific, major histocompatibility complex-unrestricted recognition of tumor- associated mucins by human cytotoxic T cells
    • COI: 1:CAS:528:DyaL1MXlslaju78%3D, PID: 2674949
    • Barnd, D.L., Lan, M.S., Metzgar, R.S., and Finn, O.J. (1989). Specific, major histocompatibility complex-unrestricted recognition of tumor- associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86, 7159–7163.
    • (1989) Proc Natl Acad Sci USA , vol.86 , pp. 7159-7163
    • Barnd, D.L.1    Lan, M.S.2    Metzgar, R.S.3    Finn, O.J.4
  • 5
    • 84895066532 scopus 로고    scopus 로고
    • Toxicity management for patients receiving novel T-cell engaging therapies
    • COI: 1:CAS:528:DC%2BC2cXnsVKmuw%3D%3D, PID: 24362408
    • Barrett, D.M., Teachey, D.T., and Grupp S.A. (2014). Toxicity management for patients receiving novel T-cell engaging therapies. Curr Opin Pediatr 26, 43–49.
    • (2014) Curr Opin Pediatr , vol.26 , pp. 43-49
    • Barrett, D.M.1    Teachey, D.T.2    Grupp, S.A.3
  • 9
    • 0027484287 scopus 로고
    • Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product
    • COI: 1:CAS:528:DyaK2cXhvV2hu7c%3D, PID: 7505698
    • Burchell, J., and Taylor-Papadimitriou, J. (1993). Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol 2, 155–162.
    • (1993) Epithelial Cell Biol , vol.2 , pp. 155-162
    • Burchell, J.1    Taylor-Papadimitriou, J.2
  • 10
    • 84863230570 scopus 로고    scopus 로고
    • Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice
    • COI: 1:CAS:528:DC%2BC38XktVynu7c%3D, PID: 22291136
    • Chinnasamy, D., Yu, Z., Kerkar, S.P., Zhang, L., Morgan, R.A., Restifo, N.P., and Rosenberg, S.A. (2012). Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clin Cancer Res 18, 1672–1683.
    • (2012) Clin Cancer Res , vol.18 , pp. 1672-1683
    • Chinnasamy, D.1    Yu, Z.2    Kerkar, S.P.3    Zhang, L.4    Morgan, R.A.5    Restifo, N.P.6    Rosenberg, S.A.7
  • 11
    • 84936934796 scopus 로고    scopus 로고
    • TRUCKs: the fourth generation of CARs
    • COI: 1:CAS:528:DC%2BC2MXhtFyqsrvN, PID: 25985798
    • Chmielewski, M., and Abken, H. (2015). TRUCKs: the fourth generation of CARs. Expert Opin Biol Ther 15, 1145–1154.
    • (2015) Expert Opin Biol Ther , vol.15 , pp. 1145-1154
    • Chmielewski, M.1    Abken, H.2
  • 12
    • 84890179288 scopus 로고    scopus 로고
    • Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
    • COI: 1:CAS:528:DC%2BC3sXhvFequrnP, PID: 24329791
    • Chmielewski, M., Hombach, A.A., and Abken H. (2014). Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Immunol Rev 257, 83–90.
    • (2014) Immunol Rev , vol.257 , pp. 83-90
    • Chmielewski, M.1    Hombach, A.A.2    Abken, H.3
  • 13
    • 84938368102 scopus 로고    scopus 로고
    • Tumor-targeted human T cells expressing CD28-based chimeric antigen receptors circumvent CTLA-4 inhibition
    • Condomines, M., Arnason, J., Benjamin R., Gunset G., Plotkin, J., and Sadelain, M. (2015). Tumor-targeted human T cells expressing CD28-based chimeric antigen receptors circumvent CTLA-4 inhibition. PLoS One 10, e0130518.
    • (2015) PLoS One , vol.10 , pp. 0130518
    • Condomines, M.1    Arnason, J.2    Benjamin, R.3    Gunset, G.4    Plotkin, J.5    Sadelain, M.6
  • 14
    • 0037238785 scopus 로고    scopus 로고
    • Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration
    • COI: 1:CAS:528:DC%2BD3sXpvVCkuw%3D%3D, PID: 12519300
    • Correa, I., Plunkett T., Vlad, A., Mungul, A., Candelora-Kettel, J., Burchell, J.M., Taylor-Papadimitriou, J., and Finn, O.J. (2003). Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration. Immunology 108, 32–41.
    • (2003) Immunology , vol.108 , pp. 32-41
    • Correa, I.1    Plunkett, T.2    Vlad, A.3    Mungul, A.4    Candelora-Kettel, J.5    Burchell, J.M.6    Taylor-Papadimitriou, J.7    Finn, O.J.8
  • 15
    • 77958063691 scopus 로고    scopus 로고
    • Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b
    • COI: 1:CAS:528:DC%2BC3cXht1WjurfL, PID: 20842059
    • Craddock, J.A., Lu, A., Bear, A., Pule, M., Brenner, M.K., Rooney, C.M., and Foster, A.E. (2010). Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b. J Immunother 33, 780–788.
    • (2010) J Immunother , vol.33 , pp. 780-788
    • Craddock, J.A.1    Lu, A.2    Bear, A.3    Pule, M.4    Brenner, M.K.5    Rooney, C.M.6    Foster, A.E.7
  • 16
    • 0035815609 scopus 로고    scopus 로고
    • The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1
    • COI: 1:CAS:528:DC%2BD3MXjvFGjsr4%3D, PID: 11118434
    • Dalziel, M., Whitehouse, C., McFarlane, I., Brockhausen, I., Gschmeissner, S., Schwientek, T., Clausen, H., Burchell, J.M., and Taylor-Papadimitriou, J. (2001). The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem 276, 11007–11015.
    • (2001) J Biol Chem , vol.276 , pp. 11007-11015
    • Dalziel, M.1    Whitehouse, C.2    McFarlane, I.3    Brockhausen, I.4    Gschmeissner, S.5    Schwientek, T.6    Clausen, H.7    Burchell, J.M.8    Taylor-Papadimitriou, J.9
  • 18
    • 84924072763 scopus 로고    scopus 로고
    • The clinical significance of hypoxia in human cancers
    • PID: 25704384
    • Dhani, N., Fyles, A., Hedley, D., and Milosevic, M. (2015). The clinical significance of hypoxia in human cancers. Semin Nucl Med 45, 110–121.
    • (2015) Semin Nucl Med , vol.45 , pp. 110-121
    • Dhani, N.1    Fyles, A.2    Hedley, D.3    Milosevic, M.4
  • 20
    • 84927798991 scopus 로고    scopus 로고
    • Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer
    • COI: 1:CAS:528:DC%2BC2cXhtl2gu7fM, PID: 25128064
    • Gheybi, E., Amani, J., Salmanian, A.H., Mashayekhi, F., and Khodi, S. (2014). Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer. Tumour Biol 35, 11489–11497.
    • (2014) Tumour Biol , vol.35 , pp. 11489-11497
    • Gheybi, E.1    Amani, J.2    Salmanian, A.H.3    Mashayekhi, F.4    Khodi, S.5
  • 23
    • 0034980598 scopus 로고    scopus 로고
    • Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus
    • COI: 1:STN:280:DC%2BD3MzhtFKksA%3D%3D, PID: 11385223
    • Gross, T., Wagner, A., Ugurel, S., Tilgen, W., and Reinhold, U. (2001). Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus. Dermatology 202, 198–202.
    • (2001) Dermatology , vol.202 , pp. 198-202
    • Gross, T.1    Wagner, A.2    Ugurel, S.3    Tilgen, W.4    Reinhold, U.5
  • 25
    • 84937760760 scopus 로고    scopus 로고
    • Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer
    • COI: 1:CAS:528:DC%2BC2MXmslaktLY%3D, PID: 25859858
    • Hillerdal, V., and Essand, M. (2015). Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer. BioDrugs 29, 75–89.
    • (2015) BioDrugs , vol.29 , pp. 75-89
    • Hillerdal, V.1    Essand, M.2
  • 26
    • 84890180201 scopus 로고    scopus 로고
    • Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
    • COI: 1:CAS:528:DC%2BC3sXhvFequrjE, PID: 24329794
    • Jensen, M.C., and Riddell, S.R. (2014). Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells. Immunol Rev 257, 127–144.
    • (2014) Immunol Rev , vol.257 , pp. 127-144
    • Jensen, M.C.1    Riddell, S.R.2
  • 27
    • 72149108714 scopus 로고    scopus 로고
    • The membrane-bound mucins: from cell signalling to transcriptional regulation and expression in epithelial cancers
    • COI: 1:CAS:528:DC%2BD1MXhsFyms73L, PID: 19818375
    • Jonckheere, N., and van Seuningen, I. (2010). The membrane-bound mucins: from cell signalling to transcriptional regulation and expression in epithelial cancers. Biochimie 92, 1–11.
    • (2010) Biochimie , vol.92 , pp. 1-11
    • Jonckheere, N.1    van Seuningen, I.2
  • 30
    • 84870931422 scopus 로고    scopus 로고
    • MUC1 immunotherapy is here to stay
    • COI: 1:CAS:528:DC%2BC38XhvVeks7vJ, PID: 22998452
    • Kimura, T., and Finn, O.J. (2013). MUC1 immunotherapy is here to stay. Expert Opin Biol Ther 13, 35–49.
    • (2013) Expert Opin Biol Ther , vol.13 , pp. 35-49
    • Kimura, T.1    Finn, O.J.2
  • 31
  • 32
    • 79953320804 scopus 로고    scopus 로고
    • CD28 costimulation Impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T cells which can be overcome by preventing Lck activation
    • COI: 1:CAS:528:DC%2BC3MXhvFCnt74%3D, PID: 21326215
    • Kofler, D.M., Chmielewski, M., Rappl, G., Hombach, A., Riet, T., Schmidt, A., Hombach, A. A., Wendtner, C.M., and Abken, H. (2011). CD28 costimulation Impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T cells which can be overcome by preventing Lck activation. Mol Ther 19, 760–767.
    • (2011) Mol Ther , vol.19 , pp. 760-767
    • Kofler, D.M.1    Chmielewski, M.2    Rappl, G.3    Hombach, A.4    Riet, T.5    Schmidt, A.6    Hombach, A.A.7    Wendtner, C.M.8    Abken, H.9
  • 33
    • 0033834497 scopus 로고    scopus 로고
    • MUC1 expression in hemopoietic tissues
    • COI: 1:CAS:528:DC%2BD3cXmvVegsrc%3D, PID: 10982236
    • Kruger, W., Kroger, N., and Zander, A.R. (2000). MUC1 expression in hemopoietic tissues. J Hematother Stem Cell Res 9, 409–410.
    • (2000) J Hematother Stem Cell Res , vol.9 , pp. 409-410
    • Kruger, W.1    Kroger, N.2    Zander, A.R.3
  • 36
    • 79960316181 scopus 로고    scopus 로고
    • Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells
    • PID: 21750545
    • Lutschg, V., Boucke, K., Hemmi, S., and Greber, U.F. (2011). Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nat Commun 2, 391.
    • (2011) Nat Commun , vol.2 , pp. 391
    • Lutschg, V.1    Boucke, K.2    Hemmi, S.3    Greber, U.F.4
  • 37
    • 84887864047 scopus 로고    scopus 로고
    • Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy
    • COI: 1:CAS:528:DC%2BC3sXhsl2iu7%2FJ, PID: 24063621
    • Madsen, C.B., Wandall, H.H., and Pedersen, A.E. (2013). Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy. Immunopharmacol Immunotoxicol 35, 649–652.
    • (2013) Immunopharmacol Immunotoxicol , vol.35 , pp. 649-652
    • Madsen, C.B.1    Wandall, H.H.2    Pedersen, A.E.3
  • 38
    • 66349117960 scopus 로고    scopus 로고
    • CAR mechanics: driving T cells into the MUC of cancer
    • COI: 1:CAS:528:DC%2BD1MXmsFGltLo%3D, PID: 19487277
    • Maher, J., and Wilkie, S. (2009). CAR mechanics: driving T cells into the MUC of cancer. Cancer Res 69, 4559–4562.
    • (2009) Cancer Res , vol.69 , pp. 4559-4562
    • Maher, J.1    Wilkie, S.2
  • 41
    • 84933510694 scopus 로고    scopus 로고
    • CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    • COI: 1:CAS:528:DC%2BC2MXhtlSnsrfI, PID: 25999455
    • Maude, S.L., Teachey, D.T., Porter, D.L., and Grupp, S.A. (2015). CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood 125, 4017–4023.
    • (2015) Blood , vol.125 , pp. 4017-4023
    • Maude, S.L.1    Teachey, D.T.2    Porter, D.L.3    Grupp, S.A.4
  • 42
    • 77950475517 scopus 로고    scopus 로고
    • Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2
    • COI: 1:CAS:528:DC%2BC3cXitlaitb4%3D, PID: 20179677
    • Morgan, R.A., Yang, J.C., Kitano, M., Dudley, M.E., Laurencot, C.M. and Rosenberg, S.A. (2010). Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 18, 843–851.
    • (2010) Mol Ther , vol.18 , pp. 843-851
    • Morgan, R.A.1    Yang, J.C.2    Kitano, M.3    Dudley, M.E.4    Laurencot, C.M.5    Rosenberg, S.A.6
  • 44
    • 84870474547 scopus 로고    scopus 로고
    • Suppression, subversion and escape: the role of regulatory T cells in cancer progression
    • COI: 1:CAS:528:DC%2BC38XhslKrtLrM, PID: 23199321
    • Oleinika, K., Nibbs, R.J., Graham, G.J., and Fraser, A.R. (2013). Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clin Exp Immunol 171, 36–45.
    • (2013) Clin Exp Immunol , vol.171 , pp. 36-45
    • Oleinika, K.1    Nibbs, R.J.2    Graham, G.J.3    Fraser, A.R.4
  • 45
    • 0026752034 scopus 로고
    • Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice
    • COI: 1:CAS:528:DyaK38XitFamsLY%3D, PID: 1372533
    • Peat, N., Gendler, S.J., Lalani, N., Duhig, T., and Taylor-Papadimitriou, J. (1992). Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res 52, 1954–1960.
    • (1992) Cancer Res , vol.52 , pp. 1954-1960
    • Peat, N.1    Gendler, S.J.2    Lalani, N.3    Duhig, T.4    Taylor-Papadimitriou, J.5
  • 46
    • 84858759305 scopus 로고    scopus 로고
    • Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
    • COI: 1:CAS:528:DC%2BC38XmvV2rsLg%3D, PID: 22354001
    • Pegram, H.J., Lee, J.C., Hayman, E.G., Imperato, G.H., Tedder, T.F., Sadelain, M., and Brentjens, R.J. (2012). Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 119, 4133–4141.
    • (2012) Blood , vol.119 , pp. 4133-4141
    • Pegram, H.J.1    Lee, J.C.2    Hayman, E.G.3    Imperato, G.H.4    Tedder, T.F.5    Sadelain, M.6    Brentjens, R.J.7
  • 47
    • 84897542755 scopus 로고    scopus 로고
    • CD28z CARs and armored CARs
    • COI: 1:CAS:528:DC%2BC2cXltFOqtrg%3D, PID: 24667958
    • Pegram, H.J., Park, J.H., and Brentjens, R.J. (2014). CD28z CARs and armored CARs. Cancer J 20, 127–133.
    • (2014) Cancer J , vol.20 , pp. 127-133
    • Pegram, H.J.1    Park, J.H.2    Brentjens, R.J.3
  • 48
    • 84922544653 scopus 로고    scopus 로고
    • IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
    • COI: 1:CAS:528:DC%2BC2cXht1Gru7zJ, PID: 25005243
    • Pegram, H.J., Purdon, T.J., van Leeuwen, D.G., Curran, K.J., Giralt, S.A., Barker, J.N., and Brentjens, R.J. (2015). IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia 29, 415–422.
    • (2015) Leukemia , vol.29 , pp. 415-422
    • Pegram, H.J.1    Purdon, T.J.2    van Leeuwen, D.G.3    Curran, K.J.4    Giralt, S.A.5    Barker, J.N.6    Brentjens, R.J.7
  • 49
    • 80051720194 scopus 로고    scopus 로고
    • Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
    • COI: 1:CAS:528:DC%2BC3MXhtV2lu7nP, PID: 21830940
    • Porter, D.L., Levine, B.L., Kalos, M., Bagg, A., and June, C.H. (2011). Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 365, 725–733.
    • (2011) N Engl J Med , vol.365 , pp. 725-733
    • Porter, D.L.1    Levine, B.L.2    Kalos, M.3    Bagg, A.4    June, C.H.5
  • 51
    • 51349164401 scopus 로고    scopus 로고
    • Strategies used for MUC1 immunotherapy: preclinical studies
    • COI: 1:CAS:528:DC%2BD1cXhtVOiur%2FJ, PID: 18767945
    • Tang, C.K., and Apostolopoulos, V. (2008). Strategies used for MUC1 immunotherapy: preclinical studies. Expert Rev Vaccines 7, 951–962.
    • (2008) Expert Rev Vaccines , vol.7 , pp. 951-962
    • Tang, C.K.1    Apostolopoulos, V.2
  • 52
    • 51349116036 scopus 로고    scopus 로고
    • Strategies used for MUC1 immunotherapy: human clinical studies
    • COI: 1:CAS:528:DC%2BD1cXhtVOiur%2FP, PID: 18767946
    • Tang, C.K., Katsara, M., and Apostolopoulos, V. (2008). Strategies used for MUC1 immunotherapy: human clinical studies. Expert Rev Vaccines 7, 963–975.
    • (2008) Expert Rev Vaccines , vol.7 , pp. 963-975
    • Tang, C.K.1    Katsara, M.2    Apostolopoulos, V.3
  • 53
    • 33846496361 scopus 로고    scopus 로고
    • Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat
    • COI: 1:CAS:528:DC%2BD2sXotFGluw%3D%3D, PID: 17050588
    • Tarp, M.A., Sorensen, A.L., Mandel, U., Paulsen, H., Burchell, J., Taylor-Papadimitriou, J., and Clausen, H. (2007). Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. Glycobiology 17, 197–209.
    • (2007) Glycobiology , vol.17 , pp. 197-209
    • Tarp, M.A.1    Sorensen, A.L.2    Mandel, U.3    Paulsen, H.4    Burchell, J.5    Taylor-Papadimitriou, J.6    Clausen, H.7
  • 55
    • 0027750805 scopus 로고
    • The role of tumor-associated antigens in the biology and immunotherapy of breast cancer
    • COI: 1:CAS:528:DyaK2cXhtVCiurc%3D
    • Taylor-Papadimitriou, J., D’Souza, B., Burchell, J., Kyprianou, N., and Berdichevsky, F. (1993). The role of tumor-associated antigens in the biology and immunotherapy of breast cancer. Ann N YA cad Sci 698, 31–47.
    • (1993) Ann N YA cad Sci , vol.698 , pp. 31-47
    • Taylor-Papadimitriou, J.1    D’Souza, B.2    Burchell, J.3    Kyprianou, N.4    Berdichevsky, F.5
  • 56
    • 84894449023 scopus 로고    scopus 로고
    • Chimeric antigen receptor modified T cell therapy for B cell malignancies
    • COI: 1:CAS:528:DC%2BC3sXhvFGhsr%2FP, PID: 24338745
    • Turtle, C.J. (2014). Chimeric antigen receptor modified T cell therapy for B cell malignancies. Int J Hematol 99, 132–140.
    • (2014) Int J Hematol , vol.99 , pp. 132-140
    • Turtle, C.J.1
  • 57
    • 84963675964 scopus 로고    scopus 로고
    • Wilkie, S., Picco, G., Foster, J., Davies, D.M., Julien, S., Cooper, L., Arif, S., Mather, S.J., Taylor-Papadimitriou, J.
    • Wilkie, S., Picco, G., Foster, J., Davies, D.M., Julien, S., Cooper, L., Arif, S., Mather, S.J., Taylor-Papadimitriou, J.
  • 58
    • 44449162630 scopus 로고    scopus 로고
    • Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor
    • PID: 18354214
    • Burchell, J.M., and Maher, J. (2008). Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor. J Immunol 180, 4901-4909.
    • (2008) J Immunol , vol.180 , pp. 4901
    • Burchell, J.M.1    Maher, J.2
  • 59
    • 34447130181 scopus 로고    scopus 로고
    • Advances of MUC1 as a target for breast cancer immunotherapy
    • COI: 1:CAS:528:DC%2BD2sXps1ahsbs%3D, PID: 17503348
    • Yang, E., Hu, X.F., and Xing P.X. (2007). Advances of MUC1 as a target for breast cancer immunotherapy. Histol Histopathol 22, 905–922.
    • (2007) Histol Histopathol , vol.22 , pp. 905-922
    • Yang, E.1    Hu, X.F.2    Xing, P.X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.